UBS Group
KRMD icon

UBS Group’s KORU Medical Systems KRMD Stock Holding History

UBS Group’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.8K Sell
5,913
-9,016
-60% -$36.9K ﹤0.01% 8021
2026
Q1 		$64.5K Sell
14,929
-2,088
-12% -$10.3K ﹤0.01% 7232
2025
Q4 		$98.9K Sell
17,017
-1,817
-10% -$8.7K ﹤0.01% 6918
2025
Q3 		$72.1K Buy
18,834
+1,565
+9% +$5.99K ﹤0.01% 7318
2025
Q2 		$61.8K Buy
17,269
+13,080
+312% +$37.2K ﹤0.01% 7595
2025
Q1 		$10.6K Buy
4,189
+1,636
+64% +$6.08K ﹤0.01% 8610
2024
Q4 		$9.83K Buy
2,553
+1,665
+188% +$5.41K ﹤0.01% 8337
2024
Q3 		$2.42K Sell
888
-17,555
-95% -$43.3K ﹤0.01% 8431
2024
Q2 		$48.9K Sell
18,443
-17,440
-49% -$39.9K ﹤0.01% 6706
2024
Q1 		$84.7K Buy
35,883
+803
+2% +$1.72K ﹤0.01% 6295
2023
Q4 		$86.1K Buy
35,080
+17,380
+98% +$41.4K ﹤0.01% 6259
2023
Q3 		$47.8K Sell
17,700
-2,812
-14% -$7.7K ﹤0.01% 6317
2023
Q2 		$70.8K Buy
20,512
+19,670
+2,336% +$77.2K ﹤0.01% 6263
2023
Q1 		$3.55K Buy
+842
New +$3.31K ﹤0.01% 8303
2022
Q2 		– Sell
-3,473
Closed -$10K – 10644
2022
Q1 		$10K Sell
3,473
-617
-15% -$1.85K ﹤0.01% 8419
2021
Q4 		$12K Buy
4,090
+668
+20% +$2.05K ﹤0.01% 8560
2021
Q3 		$10K Sell
3,422
-15,684
-82% -$51.9K ﹤0.01% 8002
2021
Q2 		$88K Buy
19,106
+13,070
+217% +$51.3K ﹤0.01% 5977
2021
Q1 		$21K Sell
6,036
-5,980
-50% -$25.9K ﹤0.01% 7335
2020
Q4 		$72K Sell
12,016
-786
-6% -$4.4K ﹤0.01% 5910
2020
Q3 		$93K Sell
12,802
-31,790
-71% -$282K ﹤0.01% 5231
2020
Q2 		$400K Buy
44,592
+29,592
+197% +$299K ﹤0.01% 4325
2020
Q1 		$113K Buy
15,000
+14,898
+14,606% +$100K ﹤0.01% 5185
2019
Q4 		$1K Buy
+102
New +$497 ﹤0.01% 7954

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $164M AUM
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
LCM
Lionhunter Capital Management New York $222M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

UBS Group's KRMD Position: Q2 2026 in Review

UBS Group reduced its KORU Medical Systems (KRMD) stake by 60% in Q2 2026, selling an estimated $36.9K and leaving 5,913 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #8021.

UBS Group first reported a position in KRMD in Q4 2019 and has held it in 24 quarters since. The position peaked at $400K in Q2 2020. 85 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

  • UBS Group held 5,913 shares of KORU Medical Systems worth $24.8K as of Q2 2026.
  • UBS Group sold 9,016 KORU Medical Systems shares in Q2 2026, an estimated $36.9K.
  • KORU Medical Systems made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8021 holding.
  • UBS Group first reported a position in KORU Medical Systems in Q4 2019 and has held it in 24 quarters since.
  • UBS Group's KORU Medical Systems position peaked at $400K in Q2 2020.
  • 85 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.